More Articles

US will continue to buy Indian generics despite quality concerns Reports | Posted 06/06/2014

According to a recent report by India’s most respected rating agency the high number of import alerts issued by the US Food and Drug Administration (FDA) in 2013 will have no impact on the existing...

Biosimilars developer Coherus raises US$55 million investment Biosimilars/News | Posted 06/06/2014

US-based biosimilars developer Coherus BioSciences (Coherus) announced on 19 May 2014 that it had raised investments of US$55 million. New investors KKR & Co LP, Venrock, RA Capital Management,...

Sun Pharma’s Gujarat site under FDA import alert Generics/News | Posted 06/06/2014

Sun Pharmaceutical Industries’ (Sun Pharma) response to the US import ban on products produced at the company’s Gujarat site is inadequate, according to a warning letter issued by the US Food and D...

Generic atypical antipsychotic drugs in Belgium Generics/Research | Posted 02/06/2014

Health authorities are continually looking to increase the utilization of low cost generics to save considerable monies without compromising care, given the ever increasing pressure on available re...

Biosimilars of bevacizumab Biosimilars/General | Posted 02/06/2014

Last update: 5 August 2016Bevacizumab is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of vascular endothelial growth factor...

FDA’s faster approval of generics to benefit Indian drugmakers Generics/General | Posted 02/06/2014

Indian generics makers are set to benefit from performance goals set by the US Food and Drug Administration (FDA) as part of the Generic Drug User Fee Amendments of 2012 (GDUFA).

ABPI issues updated position paper on biosimilars Biosimilars/General | Posted 02/06/2014

On 14 May 2014, the association that represents innovative research-based biopharmaceutical companies in the UK, the Association of the British Pharmaceutical Industry (ABPI), issued the third edit...

Patients’ perception of generics in the Philippines Reports | Posted 02/06/2014

A survey of patients in the Philippines showed that less than half were offered a generic drug alternative and even fewer asked for a generic drug alternative. The survey also revealed that patient...